Media coverage
1
Media coverage
Title Alnylam Presents Positive Complete Results from ENVISION Phase 3 Study of Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyria Media name/outlet PipelineReview Country/Territory Spain Date 13/04/19 URL www.pipelinereview.com/index.php/2019041371022/DNA-RNA-and-Cells/Alnylam-Presents-Positive-Complete-Results-from-ENVISION-Phase-3-Study-of-Givosiran-an-Investigational-RNAi-Therapeutic-for-the-Treatment-of-Acute-Hepatic-Porphyria.html Persons Manisha Balwani